Results 231 to 240 of about 186,457 (316)
Oral Immunotherapy in Peanut‐Allergic Adults Using Real‐World Materials
In 21 adults initiated on peanut oral immunotherapy (OIT), 67% tolerated at least 1000 mg on exit DBPCFC. Decreases in SPT size and increases in peanut‐ and Ara h 2‐specific IgG occurred in OIT participants but not in mechanistic controls (n = 9). Improvements were seen in FAQLQ‐AF and food neophobia scores.
Hannah Hunter+10 more
wiley +1 more source
Presence of gluten and soy derived excipients in medicinal products and their implications on allergen safety and labeling. [PDF]
Figueiredo A+4 more
europepmc +1 more source
IL‐1R2 Expression in Tfr Cells Controls Allergic Anaphylaxis by Regulating IgG Versus IgE Responses
Allergy, EarlyView.
Paul Engeroff+7 more
wiley +1 more source
SCF and TSLP expression are known to drive unique immune responses leading to the onset of allergic and inflammatory diseases. Here, we describe the characterization of a novel bsAb, CDX‐622, that targets SCF and TSLP. CDX‐622 inhibits MC functions through SCF starvation and Type 2 inflammatory responses via TSLP inhibition.
Michael B. Murphy+17 more
wiley +1 more source
Global Ragweed Allergy: Molecular Allergens and Integrated Control Strategies. [PDF]
Cheng ZL+5 more
europepmc +1 more source
This study validated AEC and NAC allergen provocation‐derived symptom severity against natural exposure during the timothy grass pollen season in allergic rhinitis patients. Both AEC and NAC tests can be effectively applied for symptom severity assessment in allergy diagnostics.
Magdalena Zemelka‐Wiacek+5 more
wiley +1 more source
Characterisation of <i>Alternaria alternata</i> Allergoids: Evaluation of the Stability of Grass Pollen Allergen Extracts Mixed with <i>Alternaria alternata</i> Allergoids. [PDF]
Abel-Fernández E+2 more
europepmc +1 more source